Allergan, Inc.
Allergan headquarters in Irvine | |
| Company type | Public |
|---|---|
| NYSE: AGN | |
| Industry | Pharmaceuticals |
| Founded | 1948 |
| Defunct | 2015 |
| Fate | Acquired by Actavis plc in 2015, who then renamed the group as Allergan plc |
| Successor | Actavis |
| Headquarters | Irvine, California, U.S. |
Area served | Over 100 Countries |
Key people | Paul Bisaro (executive chairman) |
| Products | Eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics |
| Revenue | $6.2 billion (2013) |
Number of employees | 11400 (2013) |
| Parent | Allergan plc |
| Website | www |
Allergan, Inc. was an American global pharmaceutical company focused on eye care, neurosciences, medical dermatology, medical aesthetics, breast enhancement, obesity intervention and urologics. Allergan, Inc. was formed in 1948, incorporated in 1950 and became a public company in 1970. It ceased operation in 2015 when it was acquired by Irish-based Actavis plc (itself a 2013 U.S. tax inversion to Ireland), who then renamed the group as Allergan plc.